Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis

Interferon (IFN) therapy has been reported to decrease the risk of hepatocellular carcinoma (HCC) and improve survival by preventing liver-related deaths in patients with chronic hepatitis C virus (HCV) infection, while the role of IFN therapy on the natural history of hepatitis C related cirrhosis...

Full description

Saved in:
Bibliographic Details
Main Authors: Testino, Gianni, Borro, Paolo
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Co., Limited 2013
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3812454/
https://ncbi.nlm.nih.gov/pubmed/24179611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v5.i10.521
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items